Uncategorized
Radiance Therapeutics to Present at Glaucoma 360 New Horizons Forum
SAN FRANCISCO--(BUSINESS WIRE)--Radiance Therapeutics, Inc. (RadianceTx®), an innovation leader in ophthalmic devices, today announced that Dr. Laurence Marsteller, Chief Executive Officer, will present the company at the Glaucoma Research Foundation headline event, Glaucoma 360 New Horizons 2023, that will take place on February 3rd, 2023 in San Francisco, USA. The Radiance Therapeutics presentation is part of the “Emerging Glaucoma Devices” session to be moderated by Dr. Sahar Bedrood and Dr.